Vetsys Pharmaceutical
In the contemporary "One Health" era, the role of a veterinary solutions manufacturer extends beyond simple chemical synthesis. Leading factories are now defined by their ability to provide "Information Gain"—the technical advantage achieved through proprietary R&D, molecular stability breakthroughs, and sustainable biosecurity measures. As the global demand for animal protein increases, the strategic procurement of high-stability pharmaceutical raw materials has become a critical pillar for food security and livestock productivity.
Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys), established in 2005, is a leading manufacturer in the animal pharmaceutical industry. With a registered capital of 30 million RMB, Vetsys has scaled to become a benchmark for Chinese veterinary manufacturing excellence.
We distinguish ourselves through a strong emphasis on technological development. Our independent research institute is equipped with five specialized laboratories and world-class scientists, allowing us to adapt to market demands with cutting-edge animal health solutions.
Quality is our cornerstone. Vetsys operates under strict Good Manufacturing Practices (GMP). Our comprehensive management system oversees every aspect of production, ensuring safety, efficacy, and consistency in every batch.
International buyers are moving away from reactive treatment to proactive biosecurity. There is a surge in demand for broad-spectrum disinfectants and immunity-boosting supplements like Multivitamin Oral Solutions.
Post-pandemic, the "Top 10 Manufacturers" are selected based on their vertical integration. Having in-house Injection Molding and Packaging facilities reduces lead times and ensures container integrity for sensitive liquids.
Reducing antibiotic reliance is a global mandate. The integration of Herbal Medicine Xylem Extracts into traditional treatment protocols is a major trend for sustainable livestock farming.
Factories must provide ISO and GMP certifications that meet the rigorous standards of both domestic and export markets, ensuring that products like Amoxicillin Injection are safe for food-producing animals.
Our facility includes specialized workshops for producing powders, premixes, injections, oral solutions, tablets, and herbal extracts.
Mold Injection Facility
Precision Welding
Automated Assembly Line
Final Packaging Workshop
Component Injection Molding
Container Blow Molding
Advanced Extrusion Molding
Medical Swab Processing
Controlled Drying Systems
Secondary Assembly Units
Global Logistics Packing
As Vetsys eyes global expansion, our strategy focuses on three core pillars:
Investment in green technologies and eco-friendly manufacturing to minimize environmental footprints, ensuring animal welfare aligns with planetary health.
Developing micro-granule delivery systems and long-acting injections to reduce stress on animals and improve therapeutic efficacy.
Leveraging our Fully Automatic Granule Packaging Machine technology to provide smart, anti-counterfeit packaging for international markets.
Stability is achieved through specialized solvent systems and pH-balanced formulations within our GMP workshops. This ensures the sustained release of the active ingredient over an extended period, providing consistent therapeutic levels in postpartum care.
Good Manufacturing Practice (GMP) is a system for ensuring that products are consistently produced and controlled according to quality standards. For Vetsys, it means every batch of medicine—from Tiamulin to Amoxicillin—is traceable and safe for global livestock.
Due to the increasing threat of antimicrobial resistance (AMR), plant extracts offer a natural alternative or supplement. Our research into Xylem and Woody plant extracts focuses on anti-inflammatory and immune-modulating properties without chemical residue.
Yes. Our "Customized Multi-Mineral Liquid Supplements" are designed based on the specific soil and nutritional deficiencies of various geographic regions, supporting bone metabolism and overall growth in diverse livestock populations.